Genocea Biosciences, Inc. (NASDAQ: GNCA) Dead Cat bouncing

(24/7 Market News)  Echoing the classic “you can’t fire me, I quit” line, Genocea Biosciences, Inc. (NASDAQ:GNCA) formally notified The Nasdaq Stock Market that, in conjunction with its wind down of its operations, it is going to voluntarily delist its Common Stock from the Nasdaq Capital Market, as the Nasdaq Listing Qualifications department notified the Company that it was not in compliance with the Nasdaq Marketplace requirement, due to the Company’s common stock being below $1.00 for 30 consecutive business days.

After losing $0.1621 (-72.6906%) and closing at $0.0609, on 64,975,124 shares, yesterday, it’s trading at $0.11, up a nickel (+81.12%), on 26,635,168 shares, in this morning’s premarket.

24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.

Please go to or for further information.

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.